Provided by Tiger Trade Technology Pte. Ltd.

Fractyl Health

0.6431
+0.00310.48%
Post-market: 0.66340.0203+3.16%16:00 EDT
Volume:657.49K
Turnover:427.55K
Market Cap:102.03M
PE:-0.57
High:0.6688
Open:0.6688
Low:0.6401
Close:0.6400
52wk High:2.45
52wk Low:0.3772
Shares:158.65M
Float Shares:128.00M
Volume Ratio:0.42
T/O Rate:0.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1193
EPS(LYR):-1.8600
ROE:-778.33%
ROA:-74.57%
PB:-61.28
PE(LYR):-0.35

Loading ...

Fractyl Health reports Q1 EPS 6c, consensus (16c)

TIPRANKS
·
May 13

BRIEF-Fractyl Health Reports First Quarter 2026 Financial Results

Reuters
·
May 13

Fractyl Health Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

Fractyl Health Q1 EPS $0.06 Beats $(0.16) Estimate

Benzinga Earnings
·
May 13

Fractyl Health Q1 FY26 turns to net income of $9.22 million; operating loss narrows 15.9% to $20.82 million

Reuters
·
May 13

Fractyl Health Inc - Reiterates Cash Runway Guidance Into Early 2027

THOMSON REUTERS
·
May 13

Fractyl Health Inc: Q1 EPS $0.06

THOMSON REUTERS
·
May 13

Press Release: Fractyl Health Reports First Quarter 2026 Financial Results and Business Updates

Dow Jones
·
May 13

Fractyl Health wins Dutch clearance to start RJVA-001 first-in-human trial

Reuters
·
May 11

Fractyl Health Inc - Plans Rjva-001 Study in Australia; Regulatory Feedback Expected Q3 2026

THOMSON REUTERS
·
May 11

Fractyl Health Authorized to Initiate First-in-Human Trial of Rjva-001 in the Netherlands: First Gene Therapy Candidate to Enter Clinical Development for Type 2 Diabetes

THOMSON REUTERS
·
May 11

Fractyl Health Inc - First Patient Dosing and Preliminary Data for Rjva-001 Expected in H2 2026

THOMSON REUTERS
·
May 11

Fractyl Health Inc - Rejuva Clinical Development Funded Into Early 2027 With No Change to Capital Plans

THOMSON REUTERS
·
May 11

Fractyl Health Authorized to Initiate First-in-Human Trial of RJVA-001 in the Netherlands: First Gene Therapy Candidate to Enter Clinical Development for Type 2 Diabetes

GlobeNewswire
·
May 11

Fractyl Health Inc expected to post a loss of 16 cents a share - Earnings Preview

Reuters
·
May 09

Fractyl Health updates financial calendar ahead of quarterly results webcast

Reuters
·
May 05

Fractyl Health to Report First Quarter 2026 Financial Results and Provide Business Updates on May 12, 2026, and Will Participate in an Upcoming Investor Conference

GlobeNewswire
·
May 05

Reiterated Buy on Strong Risk‑Reward Ahead of REMAIN‑1 Pivotal Data; $8 Price Target Unchanged

TIPRANKS
·
Apr 29

Fractyl Health announces annual shareholder meeting

Reuters
·
Apr 25

Fractyl Health Price Target Maintained With a $8.00/Share by HC Wainwright & Co.

Dow Jones
·
Apr 24